Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

Epilepsia

Volumn 37, Issue 6, 1996, Pages 539-543

  Ben Menachem, Elinor ^a   Henriksen, Olaf ^b   Dam, Mogens ^c   Mikkelsen, Marianne ^c   Schmidt, Dieter ^d   Reid, Sybiella ^d   Reife, Ross ^e   Kramer, Lynn ^e   Pledger, Gordon ^e   Karim, Rezaul ^e  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b National Center for Epilepsy   (Norway)

^c HVIDOVRE HOSPITAL   (Denmark)

^d Epilepsy Research Group   (Germany)

^e R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Anticonvulsants; Controlled trials; Epilepsy; Partial onset seizures; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FOCAL EPILEPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAXIMUM PERMISSIBLE DOSE; MULTICENTER STUDY; PARESTHESIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; ATTENTION; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FATIGUE; FEMALE; FRUCTOSE; HEADACHE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PARESTHESIA; PLACEBOS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0043181917     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00606.x     Document Type: Article

References (19)

1. Reynolds EH, Elwes RDC, Shorvon SD. Why does epilepsy become intractable? Prevention of chronic epilepsy. Lancet 1983;2:952-4.
2. Schmidt D. Diagnostic and therapeutic management of intractable epilepsy. In: Schmidt D, Morselli PL, eds. Intractable epilepsy: experimental and clinical aspects. New York: Raven Press, 1986.
3. Shorvon SD. Medical assessment and treatment of chronic epilepsy. Br Med J 1991;302:363-6.
4. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
5. Loiseau P. Intractable epilepsy: prognostic evaluation. In: Schmidt D, Morselli PL, eds. Intractable epilepsy: experimental and clinical aspects. New York: Raven Press, 1986.
6. Gardocki JF, Labinsky LS, Brown GL, Maryanoff BE. Anticonvulsant activity of McN-4853 (M)2,3:4,5-bis-O-(L-methy-lethylidene)-β-D-fructopyranose sulfamate in mice and rats [Abstract]. Epilepsia 1986;27:648-9.
7. Coulter DA, Sombati S, DeLorenzo RJ. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in hippocampal neurons [Abstract]. Epilepsia 1993;34(suppl 2):123.
8. Brown SD, Wolf HH, Swinyard RE, et al. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux [Abstract]. Epilepsia 1993;34(suppl 2):122-3.
9. Rangel RJ, Penry JK, Wilder BJ, Riela AL, Margul BL. Topiramate: a new antiepileptic drug for complex partial seizures - first use in epileptic patients [Abstract]. Neurology 1988;38(suppl 1):234.
10. Wilder BJ, Penry JK, Rangel RJ, Riela A, Margul BL, Marriott TB. Topiramate: efficacy, toxicity, and dose/plasma concentrations [Abstract]. Epilepsia 1988;29:698.
11. Floren KL, Graves NM, Leppik IE, Remmel RP, Margul BL, Doose DR. Pharmacokinetics of topiramate in patients with partial epilepsy receiving phenytoin or valproate [Abstract]. Epilepsia 1989;30:646.
12. Wilensky AJ, Ojemann LM, Chmelir T, Margul BL, Doose DR. Topiramate pharmacokinetics in epileptic patients receiving carbamazepine [Abstract]. Epilepsia 1989;30:645-6.
13. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
14. Conover WJ, Iman RL. Rank transformation as a bridge between parametric and nonparametric statistics. Am Statistician 1981;35:124-33.
15. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons, 1981.
16. Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden Day, 1975.
17. Faught RE. Topiramate: US trial experience in partial epilepsy. 20th International Epilepsy Congress, Oslo, Norway, 1993.
18. U.S. Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel group study. Neurology 1993;43: 2292-8.
19. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled group study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-91.